Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antiinflammatory drugs
- 1 December 1978
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 13 (6) , 1057-1065
- https://doi.org/10.1016/0049-3848(78)90234-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbitsThrombosis Research, 1978
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977
- Synthesis of prostaglandin D2 and thromboxane B2 by human plateletsThrombosis Research, 1977
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977
- Aspirin as a quantitative acetylating reagent for the fatty acid oxygenase that forms prostaglandinsProstaglandins, 1976
- Arteriovenous-Shunt ThrombosisNew England Journal of Medicine, 1974
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971
- The effect of salicylates on the hemostatic properties of platelets in manJournal of Clinical Investigation, 1968
- EFFECT OF ANTI-INFLAMMATORY AGENTS ON PLATELETSThe Lancet, 1968